Hills Bank & Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $216K | Hold |
1,412
| – | – | 0.01% | 284 |
|
|
2025
Q4 | $195K | Hold |
1,412
| – | – | 0.01% | 274 |
|
|
2025
Q3 | $181K | Hold |
1,412
| – | – | 0.01% | 268 |
|
|
2025
Q2 | $171K | Hold |
1,412
| – | – | 0.01% | 264 |
|
|
2025
Q1 | $157K | Sell |
1,412
-39
| -3% | -$4.15K | 0.01% | 265 |
|
|
2024
Q4 | $141K | Buy |
1,451
+91
| +7% | +$9.7K | 0.01% | 274 |
|
|
2024
Q3 | $156K | Sell |
1,360
-90
| -6% | -$10.2K | 0.01% | 267 |
|
|
2024
Q2 | $154K | Sell |
1,450
-1
| -0.1% | -$100 | 0.01% | 260 |
|
|
2024
Q1 | $140K | Sell |
1,451
-12
| -0.8% | -$1.23K | 0.01% | 259 |
|
|
2023
Q4 | $148K | Hold |
1,463
| – | – | 0.01% | 244 |
|
|
2023
Q3 | $149K | Buy |
1,463
+33
| +2% | +$3.35K | 0.02% | 231 |
|
|
2023
Q2 | $144K | Sell |
1,430
-219
| -13% | -$21.9K | 0.02% | 224 |
|
|
2023
Q1 | $152K | Sell |
1,649
-80
| -5% | -$6.99K | 0.02% | 225 |
|
|
2022
Q4 | $157K | Sell |
1,729
-110
| -6% | -$9.27K | 0.02% | 221 |
|
|
2022
Q3 | $140K | Buy |
1,839
+10
| +0.5% | +$829 | 0.02% | 222 |
|
|
2022
Q2 | $154K | Sell |
1,829
-156
| -8% | -$13.7K | 0.03% | 214 |
|
|
2022
Q1 | $174K | Sell |
1,985
-248
| -11% | -$21.5K | 0.02% | 213 |
|
|
2021
Q4 | $195K | Sell |
2,233
-684
| -23% | -$56.8K | 0.03% | 211 |
|
|
2021
Q3 | $238K | Sell |
2,917
-6
| -0.2% | -$540 | 0.04% | 187 |
|
|
2021
Q2 | $267K | Sell |
2,923
-85
| -3% | -$7.57K | 0.04% | 179 |
|
|
2021
Q1 | $257K | Sell |
3,008
-100
| -3% | -$8.97K | 0.04% | 175 |
|
|
2020
Q4 | $294K | Hold |
3,108
| – | – | 0.05% | 158 |
|
|
2020
Q3 | $270K | Sell |
3,108
-250
| -7% | -$21.7K | 0.05% | 152 |
|
|
2020
Q2 | $293K | Buy |
3,358
+77
| +2% | +$6.65K | 0.06% | 150 |
|
|
2020
Q1 | $270K | Sell |
3,281
-119
| -4% | -$10.6K | 0.08% | 126 |
|
|
2019
Q4 | $322K | Sell |
3,400
-100
| -3% | -$8.97K | 0.08% | 128 |
|
|
2019
Q3 | $304K | Sell |
3,500
-84
| -2% | -$7.54K | 0.08% | 124 |
|
|
2019
Q2 | $327K | Sell |
3,584
-366
| -9% | -$31K | 0.08% | 130 |
|
|
2019
Q1 | $340K | Buy |
3,950
+284
| +8% | +$22.8K | 0.09% | 120 |
|
|
2018
Q4 | $281K | Sell |
3,666
-145
| -4% | -$11.3K | 0.09% | 120 |
|
|
2018
Q3 | $295K | Sell |
3,811
-248
| -6% | -$18.3K | 0.08% | 121 |
|
|
2018
Q2 | $275K | Sell |
4,059
-1,036
| -20% | -$71.5K | 0.08% | 119 |
|
|
2018
Q1 | $369K | Sell |
5,095
-6,115
| -55% | -$466K | 0.11% | 105 |
|
|
2017
Q4 | $844K | Sell |
11,210
-327
| -3% | -$24.7K | 0.25% | 77 |
|
|
2017
Q3 | $887K | Sell |
11,537
-274
| -2% | -$20.7K | 0.28% | 72 |
|
|
2017
Q2 | $883K | Sell |
11,811
-2,302
| -16% | -$163K | 0.29% | 71 |
|
|
2017
Q1 | $940K | Sell |
14,113
-2,913
| -17% | -$194K | 0.32% | 66 |
|
|
2016
Q4 | $1.11M | Sell |
17,026
-1,567
| -8% | -$102K | 0.39% | 59 |
|
|
2016
Q3 | $1.32M | Sell |
18,593
-3,643
| -16% | -$265K | 0.48% | 51 |
|
|
2016
Q2 | $1.64M | Sell |
22,236
-1,528
| -6% | -$106K | 0.61% | 44 |
|
|
2016
Q1 | $1.54M | Sell |
23,764
-3,211
| -12% | -$218K | 0.57% | 49 |
|
|
2015
Q4 | $2.08M | Sell |
26,975
-669
| -2% | -$53.1K | 0.79% | 38 |
|
|
2015
Q3 | $2.28M | Sell |
27,644
-228
| -0.8% | -$20.3K | 0.9% | 36 |
|
|
2015
Q2 | $2.46M | Buy |
27,872
+65
| +0.2% | +$5.96K | 0.91% | 37 |
|
|
2015
Q1 | $2.46M | Buy |
27,807
+1,676
| +6% | +$149K | 0.92% | 36 |
|
|
2014
Q4 | $2.17M | Buy |
26,131
+136
| +0.5% | +$11.3K | 0.85% | 38 |
|
|
2014
Q3 | $2.19M | Buy |
25,995
+521
| +2% | +$42.2K | 0.9% | 35 |
|
|
2014
Q2 | $2.07M | Sell |
25,474
-365
| -1% | -$28.7K | 0.86% | 35 |
|
|
2014
Q1 | $1.97M | Buy |
25,839
+265
| +1% | +$19.3K | 0.84% | 35 |
|
|
2013
Q4 | $1.84M | Sell |
25,574
-221
| -0.9% | -$15.4K | 0.82% | 37 |
|
|
2013
Q3 | $1.77M | Sell |
25,795
-5
| -0% | -$331 | 0.86% | 36 |
|
|
2013
Q2 | $1.64M | Buy |
+25,800
| New | +$1.68M | 0.85% | 37 |
|
Other funds holding NVS
Hills Bank & Trust's NVS Position: Q1 2026 in Review
Hills Bank & Trust held its Novartis (NVS) position steady in Q1 2026 at 1,412 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #284.
Hills Bank & Trust first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.46M in Q1 2015. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Hills Bank & Trust held 1,412 shares of Novartis worth $216K as of Q1 2026.
- Hills Bank & Trust left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.01% of Hills Bank & Trust's portfolio in Q1 2026, its #284 holding.
- Hills Bank & Trust first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Hills Bank & Trust's Novartis position peaked at $2.46M in Q1 2015.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.